These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 27603665)

  • 1. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model.
    Ichimura K; Matoba T; Nakano K; Tokutome M; Honda K; Koga J; Egashira K
    PLoS One; 2016; 11(9):e0162425. PubMed ID: 27603665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening.
    Ikeda G; Matoba T; Nakano Y; Nagaoka K; Ishikita A; Nakano K; Funamoto D; Sunagawa K; Egashira K
    Sci Rep; 2016 Feb; 6():20467. PubMed ID: 26861678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo cardioprotection by pitavastatin from ischemic-reperfusion injury through suppression of IKK/NF-κB and upregulation of pAkt-e-NOS.
    Malik S; Sharma AK; Bharti S; Nepal S; Bhatia J; Nag TC; Narang R; Arya DS
    J Cardiovasc Pharmacol; 2011 Aug; 58(2):199-206. PubMed ID: 21654332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction.
    Ishikita A; Matoba T; Ikeda G; Koga J; Mao Y; Nakano K; Takeuchi O; Sadoshima J; Egashira K
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor-gamma targeting nanomedicine promotes cardiac healing after acute myocardial infarction by skewing monocyte/macrophage polarization in preclinical animal models.
    Tokutome M; Matoba T; Nakano Y; Okahara A; Fujiwara M; Koga JI; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Feb; 115(2):419-431. PubMed ID: 30084995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle incorporating Toll-like receptor 4 inhibitor attenuates myocardial ischaemia-reperfusion injury by inhibiting monocyte-mediated inflammation in mice.
    Fujiwara M; Matoba T; Koga JI; Okahara A; Funamoto D; Nakano K; Tsutsui H; Egashira K
    Cardiovasc Res; 2019 Jun; 115(7):1244-1255. PubMed ID: 30851101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection.
    Lu ZX; Mao LL; Lian F; He J; Zhang WT; Dai CY; Xue S; Lu WG; Zhu HS
    BMC Cardiovasc Disord; 2014 Apr; 14():53. PubMed ID: 24742302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized nanoparticles provide early cardioprotection after acute myocardial infarction.
    Chang MY; Yang YJ; Chang CH; Tang AC; Liao WY; Cheng FY; Yeh CS; Lai JJ; Stayton PS; Hsieh PC
    J Control Release; 2013 Sep; 170(2):287-94. PubMed ID: 23665256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation.
    Nakano Y; Matoba T; Tokutome M; Funamoto D; Katsuki S; Ikeda G; Nagaoka K; Ishikita A; Nakano K; Koga J; Sunagawa K; Egashira K
    Sci Rep; 2016 Jul; 6():29601. PubMed ID: 27403534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia-Reperfusion Injury.
    Ikeda G; Matoba T; Ishikita A; Nagaoka K; Nakano K; Koga JI; Tsutsui H; Egashira K
    J Am Heart Assoc; 2021 Jun; 10(12):e019521. PubMed ID: 34056918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.
    Kanazawa H; Tseliou E; Dawkins JF; De Couto G; Gallet R; Malliaras K; Yee K; Kreke M; Valle I; Smith RR; Middleton RC; Ho CS; Dharmakumar R; Li D; Makkar RR; Fukuda K; Marbán L; Marbán E
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Left Ventricular Remodeling After Acute Myocardial Infarction by Inhibiting Monocyte-Mediated Inflammation.
    Mao Y; Koga JI; Tokutome M; Matoba T; Ikeda G; Nakano K; Egashira K
    Int Heart J; 2017 Aug; 58(4):615-623. PubMed ID: 28701679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NDRG2: a newly identified mediator of insulin cardioprotection against myocardial ischemia-reperfusion injury.
    Sun Z; Tong G; Ma N; Li J; Li X; Li S; Zhou J; Xiong L; Cao F; Yao L; Wang H; Shen L
    Basic Res Cardiol; 2013 May; 108(3):341. PubMed ID: 23463182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine-1-Phosphate Receptor Agonist Fingolimod Increases Myocardial Salvage and Decreases Adverse Postinfarction Left Ventricular Remodeling in a Porcine Model of Ischemia/Reperfusion.
    Santos-Gallego CG; Vahl TP; Goliasch G; Picatoste B; Arias T; Ishikawa K; Njerve IU; Sanz J; Narula J; Sengupta PP; Hajjar RJ; Fuster V; Badimon JJ
    Circulation; 2016 Mar; 133(10):954-66. PubMed ID: 26826180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.
    Dai W; Cheung E; Alleman RJ; Perry JB; Allen ME; Brown DA; Kloner RA
    Cardiovasc Drugs Ther; 2016 Dec; 30(6):559-566. PubMed ID: 27747447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Elevated Reperfusion Pressure on "No Reflow" Area and Infarct Size in a Porcine Model of Ischemia-Reperfusion.
    Pantsios C; Kapelios C; Vakrou S; Diakos N; Pozios I; Kontogiannis C; Nanas J; Malliaras K
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):405-11. PubMed ID: 26589289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardioprotective effects of intracoronary administration of 4-chlorodiazepam in small and large animal models of ischemia-reperfusion.
    Tsamatsoulis M; Kapelios CJ; Katsaros L; Vakrou S; Sousonis V; Sventzouri S; Michelinakis N; Perrea DN; Anastasiou-Nana M; Malliaras K
    Int J Cardiol; 2016 Dec; 224():90-95. PubMed ID: 27643472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.